Spectral AI Announces Total U.S. and International Patent Portfolio Now Stands at 26 Granted Patents and 38 Pending Applications in Support of Its AI-Driven DeepView System
Spectral AI Expands Patent Portfolio, Bolstering AI-driven Wound Care Platform | NASDAQ:MDAI
Express News | Spectral AI Adds Three New Clinical Trial Sites to Expedite Emergency Department Patient Enrollment
Spectral AI Adds Three New Clinical Sites to Pivotal Burn Study | NASDAQ:MDAI
H.C. Wainwright Initiates Spectral AI(MDAI.US) With Buy Rating, Announces Target Price $3.5
Buy Rating on Spectral AI: Innovative AI-Driven Wound Care Poised for Market Disruption
Spectral AI Analyst Ratings
Express News | Spectral AI, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating and Target Price $3.5
Spectral AI Tackles Market Manipulation Concerns
Express News | Spectral AI Calls On Authorities To Investigate The Likely Prevalence Of Naked Short Selling That Is Negatively Impacting Both MDAI Shares And Many Other De-SPAC Transaction Companies
Spectral AI Continues Support of Naked Short Selling Inquiry
Spectral AI Highlights Concerns Over Stock Manipulation | NASDAQ:MDAI
Spectral AI Partners With PolyNovo to Deploy Burn Wound Diagnostics System in Australia
Express News | Spectral AI Announces Collaboration With Global Wound Care Company Polynovo to Introduce Deepview System for Burn Indication to Australian Market
Spectral AI Works With Market Leader on Initial Steps in Australia | NASDAQ:MDAI
Express News | Spectral AI Expands Clinical Trial Sites For U.S. Burn Study; 14 Total Number of Sites
Express News | Spectral AI Inc - Burn Pivotal Study to Be Completed in Q4 2024
Express News | Spectral AI Inc - Adds Two New U.S. Clinical Trial Sites
Express News | Spectral AI Expands Clinical Trial Sites for Pivotal U.S. Burn Study
Express News | Spectral AI Reaches 100% Pediatric Enrollment In Its Study Evaluating An Algorithm Used By Its DeepView System For Its Burn Indication
No Data